The protein sequencing market is a vital component of the life sciences industry, focusing on the determination of the amino acid sequence of proteins. This market plays a crucial role in various applications, including drug discovery, Proteomic Analysis, disease research, and biotechnology. Protein sequencing is essential for understanding the structure and function of proteins, providing insights into their roles in biological processes. The demand for protein sequencing services is driven by the increasing emphasis on personalized medicine, advancements in proteomics, and the need for accurate and comprehensive characterization of therapeutic proteins.

Technological advancements, particularly in mass spectrometry and next-generation sequencing techniques, have significantly enhanced the speed and accuracy of protein sequencing. Additionally, the growing complexity of biological research and the quest for targeted and precise therapeutic interventions fuel the expansion of the protein sequencing market. As the pharmaceutical and biotechnology industries continue to grow, with a focus on biopharmaceuticals and precision medicine, the demand for advanced protein sequencing technologies is expected to rise.

The protein sequencing market is also influenced by collaborations between academic research institutions and industry players, fostering innovation and the development of cutting-edge sequencing technologies. As the understanding of protein structures becomes increasingly vital in drug development and biomedical research, the protein sequencing market is poised for sustained growth, offering critical tools for unraveling the intricacies of cellular processes and advancing therapeutic discoveries.

Market Research Future (MRFR) proclaims that the global protein sequencing market size is likely to expand at a CAGR of 3.40% during the forecast period (2023-2030). The surging focus on target-based drug development by the biotechnological companies is likely to contribute to the market growth. Protein sequencing can be defined as the methods which are used to determine the amino acid sequence of peptides or proteins for analysing the sequence. It is a popular novo sequencing method which enables the researchers to obtain the information regarding protein confirmation. Target-based drug discovery is one of its prominent applications. Experimental methods and computational methods like Mass Spectrometry and Edman degradation are used for protein sequencing.

Market Potential and Pitfalls

The global protein sequencing market is witnessing a sturdy growth rate owing to the surging focus on target-based drug development by the pharmaceutical and biotechnological companies, advancements made in the clinical mass spectrometry and analytical techniques, and rising financial support by the private and public sector for proteomic research. For instance, the National Cancer Institute Office of Cancer Clinical Proteomics Research offers funding opportunities for proteomics research.

Recent advancements made in the analytical methods and novo peptide-sequencing methods with the application of neural networks have created new opportunities for the market to expand. For instance, technological advancements in mass spectrometer are likely to favor its growth. The surging funding on proteomics research in several developed and developing economies is likely to contribute to market growth. Moreover, the increased demand for protein biomarkers in the process of drug development is fueling its demand across the globe. Moreover, technological advancements in identifying isobaric residues in protein sequences is anticipated to unlock vast prospect in the market globally.

On the contrary, the high cost of the instruments like mass spectrometers and the infrastructure are likely to hinder the market growth across the globe. On a brighter note, the rising application of protein sequencing techniques in order to identify novel peptides in human antigens and antibodies are likely to boost the market in the long run.

Competitive Dashboard

The prominent players operating in the global protein sequencing market comprises Charles River Laboratories, Bioinformatics Solutions, Proteome Factory, Agilent Technologies Inc., Selvita, Rapid Novor Inc., Shimadzu Corporation, SGS, Waters Corporation, and Thermo Fisher Scientific Inc.

Global Protein Sequencing Market: Segmental Analysis

The global protein sequencing market report has been segmented on the basis of technology, products and services, and application.

By mode of products and services, the global protein sequencing market has been segmented into instruments, reagent and consumables, protein sequencing services, and analysis products/software. Among these, the reagents and consumables segment command for the largest share owing to the ongoing advancements in protein sequencing technologies coupled with the surging number of sequencing procedures.

By mode of technology, the global protein sequencing market has been segmented into Edman degradation and mass spectrometry.

By mode of application, the global protein sequencing market has been segmented into genetic engineering, biotherapeutics, and others. Among these, the biotherapeutics segment is likely to expand at the fastest rate in the coming years. The growth can be ascribed to the benefits of protein sequencing-based approaches for drug development processes, surging demand for targeted drug therapy, advancing technology that offer accurate protein sequencing with the help of mass spectrometry, and growing antibiotic resistance of microbes.

By mode of end-users, the global protein sequencing market has been segmented into academic institutes and research centers, pharmaceutical and biotechnology companies, and others.

Regional Insights

Geographically, the protein sequencing market spans across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the American region is considered to dominate the global market due to the surging application of protein sequencing in proteomic research, high availability of research funding, and the development of protein sequencing in this region.

The European region is estimated to occupy the second spot in the global market. The growth has been ascribed to the increased availability of funding along with infrastructure for research and rising proteomics research. For instance, a leading proteomics company in Switzerland, Biognosys, raised funds for making proteomics a broader segment in life science research in July 2017.

The Asia Pacific region is likely to expand at the fastest growth rate due to the increased funding for the healthcare sector, rising number of pharmaceutical companies, and growing expenditure on R&D activities in this region.

Read More: https://www.marketresearchfuture.com/